Woodard & Company Asset Management Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $218K | Sell |
866
-7,398
| -90% | -$1.59M | 0.03% | 115 |
|
|
2026
Q1 | $1.8M | Sell |
8,264
-76
| -0.9% | -$16.9K | 0.29% | 52 |
|
|
2025
Q4 | $1.91M | Buy |
8,340
+166
| +2% | +$37.8K | 0.3% | 51 |
|
|
2025
Q3 | $1.89M | Hold |
8,174
| – | – | 0.31% | 48 |
|
|
2025
Q2 | $1.52M | Sell |
8,174
-100
| -1% | -$18.6K | 0.28% | 51 |
|
|
2025
Q1 | $1.73M | Hold |
8,274
| – | – | 0.36% | 40 |
|
|
2024
Q4 | $1.47M | Hold |
8,274
| – | – | 0.32% | 46 |
|
|
2024
Q3 | $1.63M | Buy |
8,274
+34
| +0.4% | +$6.35K | 0.37% | 42 |
|
|
2024
Q2 | $1.41M | Sell |
8,240
-200
| -2% | -$33.1K | 0.35% | 42 |
|
|
2024
Q1 | $1.54M | Sell |
8,440
-100
| -1% | -$17.2K | 0.41% | 38 |
|
|
2023
Q4 | $1.32M | Hold |
8,540
| – | – | 0.39% | 38 |
|
|
2023
Q3 | $1.27M | Sell |
8,540
-118
| -1% | -$17.3K | 0.43% | 37 |
|
|
2023
Q2 | $1.17M | Buy |
8,658
+118
| +1% | +$17.3K | 0.39% | 42 |
|
|
2023
Q1 | $1.36M | Sell |
8,540
-60
| -0.7% | -$9.17K | 0.47% | 37 |
|
|
2022
Q4 | $1.39M | Buy |
8,600
+160
| +2% | +$24.5K | 0.49% | 33 |
|
|
2022
Q3 | $1.13M | Hold |
8,440
| – | – | 0.52% | 32 |
|
|
2022
Q2 | $1.29M | Sell |
8,440
-315
| -4% | -$48.1K | 0.53% | 30 |
|
|
2022
Q1 | $1.42M | Sell |
8,755
-200
| -2% | -$29.1K | 0.59% | 31 |
|
|
2021
Q4 | $1.21M | Buy |
8,955
+175
| +2% | +$20.7K | 0.58% | 26 |
|
|
2021
Q3 | $947K | Hold |
8,780
| – | – | 0.58% | 30 |
|
|
2021
Q2 | $989K | Hold |
8,780
| – | – | 0.59% | 30 |
|
|
2021
Q1 | $950K | Hold |
8,780
| – | – | 0.6% | 32 |
|
|
2020
Q4 | $941K | Hold |
8,780
| – | – | 0.58% | 29 |
|
|
2020
Q3 | $769K | Buy |
8,780
+40
| +0.5% | +$3.77K | 0.5% | 29 |
|
|
2020
Q2 | $858K | Buy |
8,740
+300
| +4% | +$26.4K | 0.58% | 30 |
|
|
2020
Q1 | $643K | Buy |
8,440
+110
| +1% | +$9.37K | 0.46% | 31 |
|
|
2019
Q4 | $738K | Buy |
8,330
+90
| +1% | +$7.47K | 0.44% | 33 |
|
|
2019
Q3 | $624K | Buy |
8,240
+700
| +9% | +$48K | 0.4% | 37 |
|
|
2019
Q2 | $548K | Hold |
7,540
| – | – | 4.23% | 4 |
|
|
2019
Q1 | $608K | Hold |
7,540
| – | – | 5.11% | 3 |
|
|
2018
Q4 | $695K | Sell |
7,540
-700
| -8% | -$61.6K | 7.03% | 3 |
|
|
2018
Q3 | $779K | Hold |
8,240
| – | – | 0.71% | 18 |
|
|
2018
Q2 | $763K | Hold |
8,240
| – | – | 0.74% | 17 |
|
|
2018
Q1 | $780K | Hold |
8,240
| – | – | 0.76% | 17 |
|
|
2017
Q4 | $797K | Buy |
+8,240
| New | +$777K | 0.69% | 16 |
|
Other funds holding ABBV
Woodard & Company Asset Management Group's ABBV Position: Q2 2026 in Review
Woodard & Company Asset Management Group reduced its AbbVie (ABBV) stake by 90% in Q2 2026, selling an estimated $1.59M and leaving 866 shares worth $218K. The position accounts for 0.03% of the portfolio, ranked #115.
Woodard & Company Asset Management Group first reported a position in ABBV in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.91M in Q4 2025. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Woodard & Company Asset Management Group held 866 shares of AbbVie worth $218K as of Q2 2026.
- Woodard & Company Asset Management Group sold 7,398 AbbVie shares in Q2 2026, an estimated $1.59M.
- AbbVie made up 0.03% of Woodard & Company Asset Management Group's portfolio in Q2 2026, its #115 holding.
- Woodard & Company Asset Management Group first reported a position in AbbVie in Q4 2017 and has held it in 35 quarters since.
- Woodard & Company Asset Management Group's AbbVie position peaked at $1.91M in Q4 2025.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Woodard & Company Asset Management Group's 13F filing for Q2 2026, filed 29 Jul 2026.